Skip to content
value.today

Cipla Limited vs Glenmark Pharmaceuticals Limited

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Cipla Limited is the larger company by market value: $12.3 B against $8.1 B for Glenmark Pharmaceuticals Limited, 1.5 times as much (market caps of Nov 20, 2026).
  • Cipla Limited had more revenue: $3.0 B against $1.8 B for Glenmark Pharmaceuticals Limited, both in the year to March 2026.
  • Cipla Limited earned more: net income of $419 M against $147 M for Glenmark Pharmaceuticals Limited.
  • Cipla Limited keeps more of each dollar of sales: a net margin of 14.0% against 8.1% for Glenmark Pharmaceuticals Limited.
  • Cipla Limited employs more people: 23,000 against 10,667 at Glenmark Pharmaceuticals Limited. Each employee brings in about $130,097 of revenue at Cipla Limited and $169,163 at Glenmark Pharmaceuticals Limited.
  • On price to earnings, Glenmark Pharmaceuticals Limited trades at 54.8× and Cipla Limited at 29.4×: investors pay more for each dollar of Glenmark Pharmaceuticals Limited's profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01442884325762020202120222023202420252026Cipla Limited 231Glenmark Pharmaceuticals Limited 576

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCipla Limited
CIPLA.BO · #1,863 in the world
Glenmark Pharmaceuticals Limited
GLENMARK.BO · #2,545 in the world
Profile
Country🇮🇳 India🇮🇳 India
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19351977
Size
Market cap$12.3 B$8.1 B
Revenue$3.0 B$1.8 B
Net income$419 M▲ best$147 M
Employees23,00010,667
Valuation
P/E ratio29.4×54.8×
Price to sales4.1×4.5×
Price to book3.3×7.1×
Altman Z-score zone——
Data as ofMarket cap Nov 2026Market cap Nov 2026

Questions and answers#

Which is bigger, Cipla Limited or Glenmark Pharmaceuticals Limited?

Cipla Limited is the larger company by market value: $12.3 B against $8.1 B for Glenmark Pharmaceuticals Limited, 1.5 times as much (market caps of Nov 20, 2026).

Which makes more money, Cipla Limited or Glenmark Pharmaceuticals Limited?

Cipla Limited had more revenue: $3.0 B against $1.8 B for Glenmark Pharmaceuticals Limited, both in the year to March 2026. Cipla Limited earned more: net income of $419 M against $147 M for Glenmark Pharmaceuticals Limited.

Which is more profitable, Cipla Limited or Glenmark Pharmaceuticals Limited?

Cipla Limited keeps more of each dollar of sales: a net margin of 14.0% against 8.1% for Glenmark Pharmaceuticals Limited.

Which has more employees, Cipla Limited or Glenmark Pharmaceuticals Limited?

Cipla Limited employs more people: 23,000 against 10,667 at Glenmark Pharmaceuticals Limited. Each employee brings in about $130,097 of revenue at Cipla Limited and $169,163 at Glenmark Pharmaceuticals Limited.

Is Cipla Limited cheaper than Glenmark Pharmaceuticals Limited?

On price to earnings, Glenmark Pharmaceuticals Limited trades at 54.8× and Cipla Limited at 29.4×: investors pay more for each dollar of Glenmark Pharmaceuticals Limited's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.